Sign in Pull a receipt

UTHR

UNITED THERAPEUTICS Corp

Biotechnology · Biotechnology

$212.06 sample

+2.63 (+1.26%) 1D

Market cap

$963.3B

Price as of

2026-10-29

Latest filing

8-K · 2026-10-16

Alerts

8

Price$212.06 +13.80% 3M daily closessample

212.22179.52

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider sell: Director
Oct 16SEC8-K filed: material event
Oct 13INSInsider buy: General Counsel
Oct 07INSInsider sell: General Counsel
Sep 30INSInsider buy: Chief Executive Officer
Sep 25INSInsider sell: Director
Sep 18SECDEF 14A filed
Sep 14INSInsider buy: Chief Financial Officer

Sign up to see the real UTHR record →

Company facts

SEC EDGAR registration

Name: UNITED THERAPEUTICS Corp
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -1sample, -100 to +100
Reporting currency: USD

Who is positioning in UTHR

sample

Insiders: 30 insider transactions over 90 days, net selling, $840.8M
Congress: 5 members traded over 90 days
Institutions · 13F: 11 funds hold $8.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$22.6B +15.0% y/y

Q4 2024Q3 2026

Inventory$13.4B +18.0% y/y

Q4 2024Q3 2026

Accounts receivable$10.2B +14.6% y/y

Q4 2024Q3 2026

Total debt$27.4B +11.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $431.3B +10.4% 3M
Sample peer B: $481.9B -7.2% 3M
Sample peer C: $485.6B +13.4% 3M
Sample peer D: $588.1B -6.2% 3M
Sample peer E: $182.7B -0.1% 3M